돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 130457생성일: 2026년 10월 26일

3-(Methoxymethyl)benzeneboronic acid → N-[5-(cis-3,5-Dimethyl-1-piperazinyl)-2-(methyloxy)phenyl]-5-{3-[(methyloxy)methyl]phenyl}-2-thiophenesulfonamide

https://huagongshe.com/reaction/130457

반응식

참여 물질

역할이름HCID투입량
반응물3-(Methoxymethyl)benzeneboronic acidHCID 3825855—
반응물Potassium tert-butoxideHCID 23665647—
반응물5-Bromo-N-[5-(cis-3,5-dimethyl-1-piperazinyl)-2-(methyloxy)phenyl]-2-thiophenesulfonamideHCID 59007058—
촉매HCID 178418397HCID 178418397—
용매WaterHCID 962—
용매1,2-DimethoxyethaneHCID 8071—
생성물N-[5-(cis-3,5-Dimethyl-1-piperazinyl)-2-(methyloxy)phenyl]-5-{3-[(methyloxy)methyl]phenyl}-2-thiophenesulfonamideHCID 59007093—

반응 조건

온도100 °C

반응 단계

To a mixture of 5-bromo-N-[5-(cis-3,5-dimethyl-1-piperazinyl)-2-(methyloxy)phenyl]-2-thiophenesulfonamide (E122) (100 mg, 0.22 mmol) and {3-[(methyloxy)methyl]phenyl}boronic acid (83 mg, 0.5 mmol) in DME (3 ml) was added potassium tert-butoxide (210 mg, 1.9 mmol) and tetrakis(triphenylphosphine)palladium(0) (15 mg, 0.013 mmol) in water (1 ml) and the resulting mixture stirred in a microwave (set at high absorbance) at 100° C. for 30 minutes. The resulting mixture was then concentrated in Genevac and residues passed over SCX. Basic fractions were re-concentrated in Genevac and the residue purified using mass directed autoprep HPLC to afford the title compound (E123). MS (ES+) m/e 502 [M+H]+.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07381728B2
출처 데이터셋uspto-grants-2008_06
ORD IDord-4c6e2ccf7dda44938fab0b983311ce43
출처 메모uspto-grants-2008_06